FCOM 2025: Trending Questions in Allergy

This panel discussion will focus on questions asked at otolaryngic allergy meetings regarding patient selection for immunotherapy, contraindications to testing or treatment, allergen selection, duration of each phase of immunotherapy, and the location of allergy immunotherapy treatment. Experts in the field will discuss their practice experience and what the literature has to say about these issues. Participants would be able to do the following: 1. Understand the rationale for deciding whether or not to test and treat patients taking beta blockers. If testing, should the testing be limited? 2. Determine if epinephrine autoinjectors should be required for patients on injection immunotherapy. 3. Decide if home or other out-of-office site of injection immunotherapy is appropriate. 4. Understand how to select allergens for testing and treatment in their geographic area. 5. Create treatment plans for patients who may reside out of state for part of the year.